Eperezolid

CAS No. 165800-04-4

Eperezolid( PNU-100592 | PNU100592 | U-100592 )

Catalog No. M12530 CAS No. 165800-04-4

An oxazolidinone antibiotic that possesses potent antimicrobial activity in vitro and in vivo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 223 In Stock
2MG 121 In Stock
5MG 202 In Stock
10MG 282 In Stock
25MG 464 In Stock
50MG 639 In Stock
100MG 863 In Stock
200MG Get Quote In Stock
500MG 1721 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Eperezolid
  • Note
    Research use only, not for human use.
  • Brief Description
    An oxazolidinone antibiotic that possesses potent antimicrobial activity in vitro and in vivo.
  • Description
    An oxazolidinone antibiotic that possesses potent antimicrobial activity in vitro and in vivo.Bacterial Infection Phase 3 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PNU-100592 | PNU100592 | U-100592
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    Infection
  • Indication
    Bacterial Infection

Chemical Information

  • CAS Number
    165800-04-4
  • Formula Weight
    394.3974
  • Molecular Formula
    C18H23FN4O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 44 mg/mL
  • SMILES
    CC(NC[C@H]1CN(C2=CC=C(C3C#[N]CCN3C(CO)=O)C(F)=C2)C(O1)=O)=O
  • Chemical Name
    Acetamide, N-[[(5S)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)-1-piperazinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ford CW, et al. Antimicrob Agents Chemother. 1996 Jun;40(6):1508-13. 2. Zurenko GE, et al. Antimicrob Agents Chemother. 1996 Apr;40(4):839-45. 3. Ford CW, et al. Antimicrob Agents Chemother. 1996 Jun;40(6):1508-13.
molnova catalog
related products
  • Linaroside

    Linaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.

  • Rifaximin

    Rifaximin is an oral, semi-synthetic antibiotic derived from Rifamycin SV with antibacterial activity.

  • GSK 951A

    A small molecule with bactericidal efficacy against Mycobacterium tuberculosis with H37Rv MIC of 0.16 uM.